A high-resolution, radiation-free full-body MRI designed to screen for structural abnormalities, tumors, organ pathology, and musculoskeletal findings. This examination evaluates brain, spine, abdominal organs, pelvis, and major soft tissue structures. Imaging is interpreted by fellowshiptrained radiologists and reviewed within your longitudinal risk framework. Findings are contextualized rather than reported in isolation

A non-invasive magnetic resonance angiography study of intracranial and extracranial arteries. This screening evaluates aneurysms, arterial narrowing, congenital variants, and vascular irregularities that may influence stroke and other risks. Given the brain-centered focus of our practice, cerebrovascular health is foundational. Results are integrated with multimodal biomarkers for further personalized contextualization.

A radiation-minimized CT scan evaluating pulmonary architecture and early lung pathology. This imaging is particularly relevant for individuals with a prior smoking history, environmental exposure, or other elevated risk factors. Nodules are assessed by size, morphology, and progression risk. Screening is performed within evidence-based guidelines.

An advanced cardiac imaging study providing direct visualization of coronary arteries. Unlike calcium scoring alone, CCTA evaluates both calcified and soft plaque burden. This allows identification of early atherosclerotic disease before clinical manifestation. Findings directly inform preventive strategy and potential targeted interventions.

Using validated artificial intelligence algorithms, coronary imaging is analyzed to quantify plaque composition and burden. This enables precise characterization of lipid-rich, fibrous, and calcified plaque. Risk is modeled beyond traditional lipid panels. Interpretation is incorporated into cardiovascular and longevity planning.

Dual-energy X-ray absorptiometry measuring bone density, lean mass, and visceral adiposity. This test provides insight into musculoskeletal resilience, fracture risk, metabolic health, and body composition optimization. Tracking lean mass over time is critical for performance and longevity. Results guide training and nutritional planning.

A full sequencing of coding and non-coding regions of your genome. This identifies inherited risk patterns across cardiovascular, neurological, oncologic, and metabolic domains. Findings inform lifetime preventive strategy rather than isolated snapshot risk. Genetic insights are interpreted conservatively and clinically.

A next-generation circulating tumor DNA screening tool designed to detect molecular signals associated with multiple cancer types. This test evaluates methylation and DNA fragment patterns associated with early malignancy. While not diagnostic, it enhances early detection strategy. Results are interpreted within clinical context.

A comprehensive neurological and cognitive performance assessment conducted by a boardcertified neurologist. This evaluation measures executive function, processing speed, working memory, and attention. Baseline assessment allows detection of subtle longitudinal decline. Findings guide both preventive and performance strategies.

An expanded laboratory panel evaluating biomarkers associated with cognitive decline and neuroinflammation. This includes metabolic, inflammatory, and genetically influenced markers correlated with long-term dementia risk. Data is contextualized within imaging and family history. The objective is mitigation decades before impairment.

An at-home polysomnographic evaluation assessing sleep structure, respiratory patterns, oxygenation, and autonomic fluctuations. Sleep architecture influences cardiovascular health, cognitive performance, and hormonal regulation. Subclinical disturbances are often underdiagnosed. Results guide targeted intervention.

A structured, high-depth medical history integrating personal, occupational, familial, and lifestyle domains. This intake exceeds traditional questionnaires and informs strategic modeling from the outset. It allows alignment between biological findings and lived reality. Precision begins with context.

A comprehensive blood panel obtained through coordinated in-home phlebotomy, or your place of choice, for whit glove service. This includes cardiovascular risk markers, metabolic function, inflammatory markers, micronutrients, neuroinflammatory indicators, and longevity-associated biomarkers. Analysis exceeds traditional annual physical panels. Results anchor longitudinal tracking.

A detailed endocrine assessment evaluating sex hormones, adrenal function, thyroid signaling, and metabolic regulators. Hormonal balance significantly influences cognition, muscle integrity, metabolic health, and mood stability. Results are interpreted strategically in coordination with multimodal testing. Optimization prioritizes physiologic restoration, not excess.

A molecular sequencing analysis evaluating microbial diversity and composition within oral and gut ecosystems. Microbiome health influences metabolic resilience, systemic inflammation, immune signaling, and cognitive function. Imbalances are addressed through precision-guided intervention. Findings are integrated with nutritional planning.

A methylation-based analysis estimating biological age relative to chronological age. Epigenetic markers provide insight into cellular aging velocity and environmental impact. Tracking biological rate of aging allows measurement of intervention effectiveness. Results are longitudinally modeled.

Standardized evaluation of blood pressure, anthropometrics, oxygen saturation, resting heart rate, and metabolic indicators. High-fidelity measurement at baseline allows precision tracking across time. Small deviations often precede large pathology. Early correction is central to preventive strategy.